CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 5 | 2011 | 933 | 1043 | 89.5% | |
| CKD 5 | 2012 | 998 | 1106 | 90.2% | |
| CKD 5 | 2013 | 1204 | 1362 | 88.4% | |
| CKD003 | 2014 | 1281 | 1433 | 89.4% | |
| CKD003 | 2015 | 1352 | 1500 | 90.1% | |
| NM84 | 2016 | 1266 | 1726 | 73.3% | |
| NM84 | 2017 | 1232 | 1714 | 71.9% | |
| NM84 | 2018 | 1227 | 1765 | 69.5% | |
| NM84 | 2019 | 753 | 1075 | 70.0% | |
| NM84 | 2020 | 671 | 1007 | 66.6% | |
| NM84 | 2022 | 636 | 949 | 67.0% | |
| NM84 | 2023 | 695 | 1001 | 69.4% |
